Syra Health Statistics
Total Valuation
Syra Health has a market cap or net worth of 901,984. The enterprise value is -1.04 million.
| Market Cap | 901,984 |
| Enterprise Value | -1.04M |
Important Dates
The next estimated earnings date is Tuesday, April 29, 2025.
| Earnings Date | Apr 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Syra Health has 17.31 million shares outstanding. The number of shares has increased by 54.81% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 17.31M |
| Shares Change (YoY) | +54.81% |
| Shares Change (QoQ) | +35.43% |
| Owned by Insiders (%) | 37.99% |
| Owned by Institutions (%) | 3.22% |
| Float | 8.83M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.11 |
| PB Ratio | 0.31 |
| P/TBV Ratio | 0.31 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.28 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 0.35 |
Financial Position
The company has a current ratio of 5.46, with a Debt / Equity ratio of 0.16.
| Current Ratio | 5.46 |
| Quick Ratio | 5.01 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.15 |
| Interest Coverage | -241.34 |
Financial Efficiency
Return on equity (ROE) is -109.09% and return on invested capital (ROIC) is -61.99%.
| Return on Equity (ROE) | -109.09% |
| Return on Assets (ROA) | -54.71% |
| Return on Invested Capital (ROIC) | -61.99% |
| Return on Capital Employed (ROCE) | -122.80% |
| Revenue Per Employee | 105,027 |
| Profits Per Employee | -49,464 |
| Employee Count | 94 |
| Asset Turnover | 1.86 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -89.77% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -89.77% |
| 50-Day Moving Average | 0.30 |
| 200-Day Moving Average | 0.58 |
| Relative Strength Index (RSI) | 20.02 |
| Average Volume (20 Days) | 1,181,458 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.40 |
Income Statement
In the last 12 months, Syra Health had revenue of 7.98 million and -3.76 million in losses. Loss per share was -0.50.
| Revenue | 7.98M |
| Gross Profit | 1.65M |
| Operating Income | -3.76M |
| Pretax Income | -3.76M |
| Net Income | -3.76M |
| EBITDA | -3.70M |
| EBIT | -3.76M |
| Loss Per Share | -0.50 |
Balance Sheet
The company has 2.40 million in cash and 452,077 in debt, giving a net cash position of 1.94 million or 0.11 per share.
| Cash & Cash Equivalents | 2.40M |
| Total Debt | 452,077 |
| Net Cash | 1.94M |
| Net Cash Per Share | 0.11 |
| Equity (Book Value) | 2.88M |
| Book Value Per Share | 0.17 |
| Working Capital | 2.74M |
Cash Flow
In the last 12 months, operating cash flow was -2.93 million and capital expenditures -11,111, giving a free cash flow of -2.94 million.
| Operating Cash Flow | -2.93M |
| Capital Expenditures | -11,111 |
| Free Cash Flow | -2.94M |
| FCF Per Share | -0.17 |
Margins
Gross margin is 20.71%, with operating and profit margins of -47.17% and -47.10%.
| Gross Margin | 20.71% |
| Operating Margin | -47.17% |
| Pretax Margin | -47.10% |
| Profit Margin | -47.10% |
| EBITDA Margin | -46.38% |
| EBIT Margin | -47.17% |
| FCF Margin | n/a |
Dividends & Yields
Syra Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -54.81% |
| Shareholder Yield | -54.81% |
| Earnings Yield | -416.77% |
| FCF Yield | -326.30% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Syra Health has an Altman Z-Score of 8.24.
| Altman Z-Score | 8.24 |
| Piotroski F-Score | n/a |